PRLD vs STE · rev $6.5M vs P/E 25, rev $5.46B
Prelude Therapeutics Inc (PRLD) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported PRLD revenue for 2025-09-30 was $6.5M. Net income was -$83.0M. Revenue was up 116.7% from 2024-09-30 to 2025-09-30. PRLD currently screens at market cap $346.5M.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
PRLD currently screens at market cap $346.5M. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the PRLD and STE stock pages for the full models.
Not investment advice.